46.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$46.78
Aprire:
$46.6976
Volume 24 ore:
8,645
Relative Volume:
0.69
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-2.00%
1M Prestazione:
+6.94%
6M Prestazione:
+40.17%
1 anno Prestazione:
+11.77%
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Nome
Global X Genomics Biotechnology Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta GNOM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
GNOM
Global X Genomics Biotechnology Etf
|
46.20 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
334.36 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
678.84 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
679.79 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
259.79 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
611.75 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Borsa (GNOM) Ultime notizie
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World
Touchstone Climate Transition ETF (OTCMKTS:HEAT) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
5 Small-cap Biotech ETFs to Watch - Investing News Network
Liquidity Mapping Around (GNOM) Price Events - news.stocktradersdaily.com
Flow Traders U.S. LLC Buys 82,063 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Flow Traders U.S. LLC Has $1.71 Million Position in Avantis Short-Term Fixed Income ETF $AVSF - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Biglari (NYSE:BH) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
The Next Big Theme: November 2025 - Global X ETFs
Syfe 2025 Thematic Portfolios Reoptimisation: Enhancing China Growth, Tech, ESG, and Healthcare Exposure - Syfe
Flowserve (NYSE:FLS) Rating Lowered to Buy at Wall Street Zen - Defense World
Why (GNOM) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Understanding Momentum Shifts in (GNOM) - news.stocktradersdaily.com
Atria Investments Inc Boosts Stake in Global X Genomics & Biotechnology ETF $GNOM - Defense World
Global X Genomics & Biotechnology ETF (GNOM) Stock Price Quote Today & Current Price Chart - Capital.com
Avoiding Lag: Real-Time Signals in (GNOM) Movement - news.stocktradersdaily.com
Global X Genomics & Biotechnology ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh - TradingView
Biotechnology: Pioneering The Future Of Medicine - Seeking Alpha
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Biotechnology: Pioneering the Future of Medicine - Global X ETFs
The Convergence Investor’s Cheat Sheet: 127 Companies Positioned at the Intersection of Future Technologies - DataDrivenInvestor
Astoria US Quality Growth Kings ETF (NASDAQ:GQQQ) Sees Large Increase in Short Interest - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Update - Defense World
First Trust Health Care AlphaDEX Fund (NYSEARCA:FXH) Short Interest Up 187.5% in September - Defense World
Discipline and Rules-Based Execution in GNOM Response - news.stocktradersdaily.com
The Next Big Theme: October 2025 - Global X ETFs
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
These 3 Biotech ETFs Have Gone Viral, and They All Offer Traders a Cure - MSN
The Next Big Theme: September 2025 - Global X ETFs
6 Best AI Drug Discovery Stocks in 2025 - StocksToTrade
HighTower Advisors LLC Acquires 2,184 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Re-rating Opportunities in Health Care Amid Sector Rotation and Regulatory Risk - AInvest
Investment Guide to Genetics Stocks and ETFs - NAI500
Investing in the DNA of Tomorrow: Explore Gene Stocks and Genomics ETFs - Investing News Network
How to Invest in Gene Stocks and ETFs - Nasdaq
The Next Big Theme: August 2025 - Seeking Alpha
Global X Announces Five ETF Reverse Stock Splits - Eastern Progress
7 Best Biotech ETFs to Buy Now - US News Money
Alnylam Pharmaceuticals Surges 3.79% Intraday – What’s Fueling This Sudden Rally? - AInvest
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Global X Fds Genomics & Biotechnology Etf To Carry Out 1-for-4 Reverse Stock Split On September 2nd, 2025 - 富途牛牛
The Next Big Theme: July 2025 - Seeking Alpha
Stratos Wealth Partners LTD. Buys 2,865 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - 富途牛牛
Middlefield Healthcare Dividend ETF: A Strategic Play on Dividend Income and Sector Resilience - AInvest
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Price Passes Above 200-Day Moving Average of $13.45 - 富途牛牛
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Position Increased by Portland Global Advisors LLC - 富途牛牛
(GNOM) Investment Analysis and Advice - news.stocktradersdaily.com
Jack Reed Net Worth - Quiver Quantitative
The long game: ASX ETFs to target amidst an ageing population - The Motley Fool Australia
Global X Genomics Biotechnology Etf Azioni (GNOM) Dati Finanziari
Non sono disponibili dati finanziari per Global X Genomics Biotechnology Etf (GNOM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):